Masaru Matsuda - Net Worth and Insider Trading
Masaru Matsuda Net Worth
The estimated net worth of Masaru Matsuda is at least $3 Million dollars as of 2024-12-29. Masaru Matsuda is the See Remarks of Arcutis Biotherapeutics Inc and owns about 187,030 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $3 Million. Details can be seen in Masaru Matsuda's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Masaru Matsuda has not made any transactions after 2024-11-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Masaru Matsuda
Masaru Matsuda Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Masaru Matsuda owns 2 companies in total, including Halozyme Therapeutics Inc (HALO) , and Arcutis Biotherapeutics Inc (ARQT) .
Click here to see the complete history of Masaru Matsuda’s form 4 insider trades.
Insider Ownership Summary of Masaru Matsuda
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2020-01-03 | SVP & General Counsel |
| ARQT | Arcutis Biotherapeutics Inc | 2024-11-30 | SVP and General Counsel |
Masaru Matsuda Latest Holdings Summary
Masaru Matsuda currently owns a total of 1 stock. Masaru Matsuda owns 187,030 shares of Arcutis Biotherapeutics Inc (ARQT) as of November 30, 2024, with a value of $3 Million.
Latest Holdings of Masaru Matsuda
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics Inc | 2024-11-30 | 187,030 | 14.30 | 2,674,529 |
Holding Weightings of Masaru Matsuda
Masaru Matsuda Form 4 Trading Tracker
According to the SEC Form 4 filings, Masaru Matsuda has made a total of 11 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 1 buys and 10 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the acquisition of 5,657 shares on November 30, 2024, which cost Masaru Matsuda around $18,555.
Insider Trading History of Masaru Matsuda
- 1
Masaru Matsuda Trading Performance
GuruFocus tracks the stock performance after each of Masaru Matsuda's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Masaru Matsuda is %. GuruFocus also compares Masaru Matsuda's trading performance to market benchmark return within the same time period. The performance of stocks bought by Masaru Matsuda within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Masaru Matsuda's insider trading performs compared to the benchmark.
Performance of Masaru Matsuda
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.95 |  | | | | |
| Relative Return to S&P 500(%) | 16.63 | | | | | |
Masaru Matsuda Ownership Network
Masaru Matsuda Owned Company Details
What does Halozyme Therapeutics Inc do?
Who are the key executives at Halozyme Therapeutics Inc?
Masaru Matsuda is the SVP & General Counsel of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & Chief Financial Officer Nicole Labrosse .
Halozyme Therapeutics Inc (HALO) Insider Trades Summary
Over the past 18 months, Masaru Matsuda made no insider transaction in Halozyme Therapeutics Inc (HALO). Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 270,000 shares made by Michael J. Labarre , a net sale of 200,000 shares made by Helen Torley , and a net sale of 49,881 shares made by Matthew L. Posard .
In summary, during the past 3 months, insiders sold 40,000 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 40,000 shares. During the past 18 months, 574,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 574,881 shares.
Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Halozyme Therapeutics Inc Insider Transactions
Masaru Matsuda Mailing Address
Above is the net worth, insider trading, and ownership report for Masaru Matsuda. You might contact Masaru Matsuda via mailing address: 11388 Sorrento Valley Road, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
